← Leaderboards
Aryan Mangalam Namboodiri
Henry M. Jackson Fdn For The Adv Mil/Med
$2,420,808
Attributed
$2,420,808
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $375.2K · FY2005–15$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$2,420,808 · 5
By mechanism
R21$1,540,923 · 3
R01$534,060 · 1
R56$345,825 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Acetates”
- Katherine Beebe Devarney · Titan Pharmaceuticals, Inc.$16,328,440
- Roberta K Merkle · University Of Georgia (Uga)$9,876,775
- Kristy M Ainslie · Univ Of North Carolina Chapel Hill$9,343,572
- Fred D Lublin · Mount Sinai School Of Medicine Of Nyu$9,247,426
- Charles Morrison · Family Health International$9,208,919
- Walter Nmn Ling · University Of California Los Angeles$8,911,125
Research focus
AcetatesChronicBrainSeizuresLaboratory MouseElectron MicroscopyBehavior TestN-AcetylaspartateClinical TrialsLipidsAspartoacylaseAffectAcetyl Coenzyme AEfficacy TestingMutationAnimal ModelCanavan DiseaseGene TargetingCessation Of LifeChildGenesAspartateLipid BiosynthesisMyelin
Grant awards (11)
Acetate Supplementation as a therapeutic strategy for Canavan disease$189,891
R21 · FY2015 · NS · contact PI
Acetate Supplementation as a therapeutic strategy for Canavan disease$227,869
R21 · FY2014 · NS · contact PI
Intranasal CNS delivery of drugs against organophosphorous threat agents$375,214
R21 · FY2013 · NS · contact PI
Intranasal CNS delivery of drugs against organophosphorous threat agents$375,214
R21 · FY2012 · NS · contact PI
Canavan Disease: Pathogenesis and Treatment$38,025
R56 · FY2008 · NS · contact PI
Canavan Disease: Pathogenesis and Treatment$307,800
R56 · FY2007 · NS · contact PI
Biosynthesis of N-acetylaspartate$203,310
R21 · FY2005 · MH
Biosynthesis of N-acetylaspartate$169,425
R21 · FY2004 · MH
CANAVAN DISEASE PATHOGENESIS AND TREATMENT$185,250
R01 · FY2002 · NS
CANAVAN DISEASE PATHOGENESIS AND TREATMENT$185,250
R01 · FY2001 · NS
CANAVAN DISEASE PATHOGENESIS AND TREATMENT$163,560
R01 · FY2000 · NS